About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 63872 record(s)
Req # A-2023-000994
The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Estradiol Abbreviated New Drug Submission (ANDS) which appears on the Generic Submissions Under Review (GSUR) List.Organization: Health Canada
November 2023
Req # A-2023-000997
Details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company 9226-6709 Québec Inc. (NEQ: 1166807389). Address: 515 l'Avenir St., Québec, QC G1E 5E8.Organization: Health Canada
November 2023
Req # A-2023-001044
Obtain details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company. Company: Maison Isabelle inc. (NEQ: 1176226232). 95 Radnor St., Trois-Rivières, QC G8T 2E6.Organization: Health Canada
November 2023
Req # A-2020-001112
Adverse Drug Reactions (ADRs). Report numbers: E2B_02074491, E2B_02075650, E2B_02076081, E2B_02076428, E2B_02077572, E2B_02077995, E2B_02078001, E2B_02081073, E2B_02082449, E2B_02084090, E2B_02088710, E2B_02091938, E2B_02094774, E2B_02095027, E2B_02102410, E2B_02104204, E2B_02105075, E2B_02106808, E2B_02107364, E2B_02109368.Organization: Health Canada
November 2023
Req # A-2020-001215
Adverse Drug Reactions (ADRs). Report numbers: E2B_02499311, E2B_02499388, E2B_02499863, E2B_02500524, E2B_02501051, E2B_02501996, E2B_02502002, E2B_02502004, E2B_02502019, E2B_02502112, E2B_02502123, E2B_02502174, E2B_02502200, E2B_02502201, E2B_02502211, E2B_02502212, E2B_02502815, E2B_02502994, E2B_02503309, E2B_02503692.Organization: Health Canada
November 2023
Req # A-2020-001363
Adverse Drug Reactions (ADRs). Report numbers: E2B_02759984, E2B_02759991, E2B_02759992, E2B_02759993, E2B_02759995, E2B_02759999, E2B_02760000, E2B_02760008, E2B_02760014, E2B_02760016, E2B_02760018, E2B_02760028, E2B_02760052, E2B_02760062, E2B_02760069, E2B_02760080, E2B_02760222, E2B_02760224, E2B_02760227, E2B_02760234.Organization: Health Canada
November 2023
Req # A-2020-001398
Adverse Drug Reactions (ADRs). Report numbers: E2B_02923744, E2B_02923770, E2B_02923787, E2B_02923791, E2B_02923797, E2B_02923798, E2B_02924527, E2B_02924704, E2B_02924958, E2B_02925846, E2B_02926149, E2B_02926635, E2B_02926636, E2B_02927181, E2B_02927400, E2B_02927561, E2B_02928196, E2B_02928210, E2B_02928318, E2B_02928406.Organization: Health Canada
November 2023
Req # A-2021-000111
Adverse Drug Reactions (ADRs) for Cipralex. Report numbers: 913781, E2B_03222881, E2B_03209564, 914535, 913955, E2B_03201921, E2B_03242954, E2B_03260823 , E2B_03230378, 916963, 919987, E2B_03321958, 920020.Organization: Health Canada
November 2023
Req # A-2021-000439
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100121-662.Organization: Health Canada
November 2023
Req # A-2021-001029
Adverse Drug Reactions (ADRs). Report numbers: E2B_01899783, E2B_01918621, E2B_01958799, E2B_01983423, E2B_02123327, E2B_02125660, E2B_02183567, E2B_02201561, E2B_02260351, E2B_02230110, E2B_02229967.Organization: Health Canada
November 2023